Posiphen is a compound under investigation in clinical trials for Alzheimer's disease. It is supplied as a pharmaceutical raw material for research and development purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 116839-68-0
Physostigmine salicylate
pharmaceutical raw material
Diatrizoic acid
pharmaceutical raw material
Etoposide phosphate
pharmaceutical raw material
Oxacillin sodium
pharmaceutical raw material
1-[(9H-Carbazol-4-yl)oxy]-3-{[(²H₇)propan-2-yl]amino}propan-2-ol
pharmaceutical raw material
[(3aS,8bR)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-phenylcarbamate
PBHFNBQPZCRWQP-AZUAARDMSA-N
C[C@]12CCN([C@H]1N(C3=C2C=C(C=C3)OC(=O)NC4=CC=CC=C4)C)C